SB 992 (see companion bill HB 1338) – MarylandStatus: Inactive / Dead
Year Introduced: 2019
Requiring the Prescription Drug Monitoring Program to disclose prescription monitoring data, in accordance with certain regulations, to the medical director or authorized administrator of certain health care facilities, or the medical director’s or authorized administrator’s designee, for the purpose of providing medical or pharmaceutical treatment to a patient or prospective patient of the health care facility.
Return to Database Search
© 2018-2019 The SLIHCQ Database. Initial funding for this project was provided by the Robert Wood Johnson Foundation. The views expressed here do not necessarily reflect the views of the Foundation.